Mraz, Amerine & Associates, Inc. Novartis Ag Transaction History

Mraz, Amerine & Associates, Inc.

$521 Million
Q3 2024

A detailed history of Mraz, Amerine & Associates, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Mraz, Amerine & Associates, Inc. holds 4,592 shares of NVS stock, worth $485,695. This represents 0.1% of its overall portfolio holdings.

Number of Shares

4,592

Previous 6,298 27.09%

Holding current value

$485,695

Previous $670,000 21.19%

% of portfolio

0.1%

Previous 0.15%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$106.13 - $120.89 $181,057 - $206,238	-1,706 Reduced 27.09%	4,592 $528,000
Q2 2024 Aug 01, 2024	SELL	$92.57 - $107.37 $9,257 - $10,737	-100 Reduced 1.56%	6,298 $670,000
Q1 2024 May 15, 2024	SELL	$95.27 - $108.47 $3,143 - $3,579	-33 Reduced 0.51%	6,398 $618,000
Q2 2023 Jul 25, 2023	BUY	$92.52 - $104.91 $3,700 - $4,196	40 Added 0.63%	6,431 $648,000
Q3 2022 Oct 25, 2022	BUY	$74.61 - $87.26 $18,354 - $21,465	246 Added 4.0%	6,391 $486,000
Q2 2022 Jul 27, 2022	SELL	$80.52 - $93.75 $8,052 - $9,375	-100 Reduced 1.6%	6,145 $519,000
Q3 2020 Nov 03, 2020	SELL	$82.14 - $91.0 $82,140 - $91,000	-1,000 Reduced 13.8%	6,245 $543,000
Q1 2020 May 06, 2020	SELL	$70.67 - $99.01 $4,310 - $6,039	-61 Reduced 0.83%	7,245 $597,000
Q1 2018 May 14, 2018	BUY	$70.39 - $84.15 $7,039 - $8,415	100 Added 1.39%	7,306 $591,000
Q4 2017 Feb 05, 2018	SELL	$72.33 - $77.64 $43,398 - $46,584	-600 Reduced 7.69%	7,206 $605,000
Q3 2017 Nov 06, 2017	BUY	$74.14 - $77.27 $578,736 - $603,169	7,806	7,806 $670,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $228B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mraz, Amerine & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mraz, Amerine & Associates, Inc. with notifications on news.

Account

Mraz, Amerine & Associates, Inc. Novartis Ag Transaction History